WallStSmart

Hinge Health, Inc. (HNGE)vsMiniMed Group, Inc. Common Stock (MMED)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

MiniMed Group, Inc. Common Stock generates 391% more annual revenue ($2.89B vs $587.86M). MMED leads profitability with a -7.3% profit margin vs -89.9%. MMED earns a higher WallStSmart Score of 37/100 (F).

HNGE

Hold

36

out of 100

Grade: F

Growth: 7.3Profit: 3.5Value: 5.0Quality: 5.0
Piotroski: 3/9Altman Z: -2.71

MMED

Hold

37

out of 100

Grade: F

Growth: 5.3Profit: 3.5Value: 5.0Quality: 5.0

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HNGE2 strengths · Avg: 10.0/10
Revenue GrowthGrowth
45.6%10/10

Revenue surging 45.6% year-over-year

Debt/EquityHealth
0.0210/10

Conservative balance sheet, low leverage

MMED0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

HNGE4 concerns · Avg: 2.8/10
Price/BookValuation
17.8x4/10

Trading at 17.8x book value

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-132.9%2/10

ROE of -132.9% — below average capital efficiency

EPS GrowthGrowth
-80.8%2/10

Earnings declined 80.8%

MMED4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Operating MarginProfitability
1.4%3/10

Operating margin of 1.4%

Free Cash FlowQuality
$-53.00M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : HNGE

The strongest argument for HNGE centers on Revenue Growth, Debt/Equity. Revenue growth of 45.6% demonstrates continued momentum.

Bull Case : MMED

Revenue growth of 13.1% demonstrates continued momentum.

Bear Case : HNGE

The primary concerns for HNGE are Price/Book, Piotroski F-Score, Return on Equity.

Bear Case : MMED

The primary concerns for MMED are EPS Growth, Return on Equity, Operating Margin.

Key Dynamics to Monitor

HNGE profiles as a hypergrowth stock while MMED is a turnaround play — different risk/reward profiles.

HNGE is growing revenue faster at 45.6% — sustainability is the question.

HNGE generates stronger free cash flow (63M), providing more financial flexibility.

Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MMED scores higher overall (37/100 vs 36/100) and 13.1% revenue growth. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Hinge Health, Inc.

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Hinge Health, Inc. develops health care software for joint and muscle health. The company is headquartered in San Francisco, California.

Visit Website →

MiniMed Group, Inc. Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Minimed Group, Inc. is a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company is headquartered in Northridge, California.

Want to dig deeper into these stocks?